Research into Bipolar i disorder spans multiple therapeutic approaches and trial phases.

19 total trials for this combination

Showing top 10 of 19 trials

Trials

NCT ID	Title	Status	Phase
NCT03573297	A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features	COMPLETED	PHASE3
NCT03201757	Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831	COMPLETED	PHASE3
NCT01358357	Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex	COMPLETED	PHASE3
NCT04578756	Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder	COMPLETED	PHASE3
NCT03187769	Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder	COMPLETED	PHASE3
NCT04777357	A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	RECRUITING	PHASE3
NCT07172516	A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	RECRUITING	PHASE3
NCT01567527	Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients	COMPLETED	PHASE3
NCT04030143	A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder	COMPLETED	PHASE1/PHASE2
NCT05648591	Safety and Tolerability of Open-Labeled Iloperidone in Adolescents	RECRUITING	PHASE4

Related Pages

All Bipolar i disorder trials All trials in Atlanta, United States